No immediate trading action warranted. The nomination is routine and non-material. Monitor the Annual General Meeting date for shareholder vote outcome, but no stock-moving catalyst is expected from this event alone.
Price Chart
Executive Summary
ProQR announced the nomination of Lykke Hinsch Gylvin, MD, EMBA, Chief Medical Officer and Head of Global Medicine at Boehringer Ingelheim, to its Board of Directors, subject to shareholder approval at the upcoming Annual General Meeting. This is a routine board nomination with no financial terms disclosed and no impact on the company's pipeline, financials, or operations.
Key Facts
- Nominee: Lykke Hinsch Gylvin, MD, EMBA, currently CMO and Head of Global Medicine at Boehringer Ingelheim
- Prior roles include senior leadership at Novartis, AstraZeneca, Roche, Novo Nordisk, and Lundbeck
- Nomination requires shareholder approval at the upcoming Annual General Meeting
- If appointed, she will serve as an independent non-executive director
- No financial terms, compensation, or material changes to the company disclosed
Financial Impact
No financial impact — no monetary terms disclosed
Risk Factors
- Shareholder vote could fail, though unlikely for a qualified independent director nominee
- No impact on pipeline, financials, or operational outlook
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3284762 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 6-K | $1.70 $1.66 | ▼ −2.35% | ▼ −1.68% | $1.34 (−21.18%) |
Sep 9, 2026 6w ago | 6-K | $1.99 $1.86 | ▼ −6.53% | ▼ −5.44% | $1.34 (−32.66%) |
Jul 16, 2026 14w ago | EFFECT | $1.67 $1.79 | ▼ −7.19% | ▼ −8.86% | $1.34 (+19.76%) |
Jun 25, 2026 17w ago | 6-K | $1.53 $1.81 | ▼ −18.30% | ▼ −16.13% | $1.34 (+12.42%) |
Jun 25, 2026 17w ago | 424B5 | $1.53 $1.81 | ▲ +18.30% | ▲ +16.13% | $1.34 (−12.42%) |
Jun 2, 2026 21w ago | 6-K | $1.47 $1.41 | ▼ −4.08% | ▼ −0.26% | $1.34 (−8.84%) |
May 12, 2026 24w ago | 6-K | $1.60 $1.51 | ▲ +5.63% | ▲ +5.70% | $1.34 (+16.25%) |
Apr 30, 2026 25w ago | 6-K | $1.57 $1.72 | ▲ +9.55% | ▲ +7.83% | $1.34 (−14.65%) |
Apr 30, 2026 25w ago | Press Release | $1.57 $1.72 | ▲ +9.55% | ▲ +7.83% | $1.34 (−14.65%) |
Apr 8, 2026 28w ago | 6-K | $1.98 $1.95 | ▼ −1.52% | ▼ −4.70% | $1.34 (−32.32%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers